CRVS · Corvus Pharmaceuticals, Inc.
Market Cap
$1.19B
Shares
84.12M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-12 | 5,253 | $14.73 | $77,377 |
| 2026-08-05 | 36 | $13.92 | $501 |
| 2026-07-29 | 9,962 | $13.31 | $132,594 |
| 2026-07-22 | 3,643 | $14.47 | $52,714 |
| 2026-07-21 | 15,919 | $14.10 | $224,458 |
| 2026-07-17 | 248 | $14.27 | $3,539 |
| 2026-07-09 | 2,564 | $16.08 | $41,229 |
| 2026-07-08 | 1 | $15.63 | $16 |
| 2026-07-01 | 8,584 | $14.94 | $128,245 |
| 2026-06-30 | 12,844 | $14.48 | $185,981 |
| 2026-06-23 | 2,679 | $12.56 | $33,648 |
| 2026-06-16 | 1,504 | $11.90 | $17,898 |
| 2026-06-15 | 1,000 | $11.93 | $11,930 |
| 2026-06-12 | 2,932 | $11.60 | $34,011 |
Showing 1–14 of 14 settlements
Key facts
CIK
1626971
CUSIP
221015100
13F (30d)
139 filings
139 filers
Visit website
Investor relations